Drug · DIN 02356503
RELISTOR
12 MG/0.6 ML SINGLE USE PREFILLED SYRINGES
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since February 3, 2012.
- Drug Identification Number (DIN)
- 02356503
- Company (DIN owner)
- Salix Pharmaceuticals IncBridgewater, New Jersey, United States
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Methylnaltrexone bromide A06AH01
- Class
- Human
- Record last updated
- August 20, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| METHYLNALTREXONE BROMIDE | 20 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 3, 2012: NOC 13013New Drug Submission (NDS) · Manufacturer name change
- September 29, 2010: NOC 11752New Drug Submission (NDS) · Manufacturer name change
- September 17, 2010: NOC 11717Supplement to a New Drug Submission (SNDS) · New dosage format and new manufacturing site
Other DINs named RELISTOR
- DIN 02308215 · Marketed
- DIN 02356481 · Approved